After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Tactile Systems Technology Inc (TCMD) shows that investor sentiment remained same, with the stock’s consolidated last price to $11.33. The Tactile Systems Technology Inc has recorded 5,073 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that LifeLens Technologies Expands Executive Leadership Team and Board of Directors.
TCMD belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $11.33 and fluctuated between $11.60 as its day high and $11.05 as its day low. The current market capitalization of Tactile Systems Technology Inc is $266.25M. A total of 0.57 million shares were traded on the day, compared to an average of 420.85K shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, TCMD has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 16 BUYs and 13 SELLs from insiders. Insiders purchased 189,912 shares during that period but sold 23,098.
In the most recent transaction, REUVERS DANIEL L. sold 1,062 shares of TCMD for 20.53 per share on Aug 07. After the transaction, the President and CEO now owns 125,653 company shares. In a previous transaction on May 12, BURKE WILLIAM W sold 4,400 shares at 21.86 per share. TCMD shares that Director owns now total 27,773.
Among the insiders who sold shares, Burns Kristie disposed of 786 shares on May 08 at a per-share price of $18.65. This resulted in the Sr. VP Mktg & Clinical Affairs holding 36,562 shares of TCMD after the transaction. In another insider transaction, PAULS ERIC sold 550 shares at $18.55 per share on May 08. Company shares held by the Senior VP, Sales now total 29,498.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for TCMD in the last 3 months, the mean price target is $24.00 with high estimates of $30.00 and low estimates of $19.00. In terms of 52-week highs and lows, TCMD has a high of $26.11 and a low of $8.01.
As of this writing, TCMD has an earnings estimate of $TherapeuticsMD, Inc. per share for the current quarter. EPS was calculated based on a consensus of TORM plc estimates, with a high estimate of $Zhongchao Inc. per share and a lower estimate of $Tactile Systems Technology, Inc.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. TCMD’s latest balance sheet shows that the firm has $40.71M in Cash & Short Term Investments as of fiscal 2021. There were $83.86M in debt and $34.46M in liabilities at the time. Its Book Value Per Share was $7.78, while its Total Shareholder’s Equity was $128.23M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TCMD is Buy with a score of 5.00.